U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852092) titled 'Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects' on Feb. 24.
Brief Summary: To evaluate the absorption, metabolism and excretion in healthy Chinese male subjects after a single oral dose of [14C]HSK39297
Study Start Date: Sept. 09, 2024
Study Type: INTERVENTIONAL
Condition:
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Intervention:
DRUG: Carbon-14 labeled HSK39297
Dose A
Recruitment Status: COMPLETED
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Disclaimer: Curated by HT Syndication....